A rare case of metastasized non-functional pancreatic neuroendocrine tumor with a good long-term survival.

Related Articles

A rare case of metastasized non-functional pancreatic neuroendocrine tumor with a good long-term survival.

J Med Life. 2016 Oct-Dec;9(4):369-372

Authors: Mirică A, Bădărău IA, Mirică R, Păun S, Păun DL

Abstract
Background: Non-functional neuroendocrine tumors of the pancreas (NF-pNETs) are a varied group of extremely rare malignancies. The majority of patients already have liver metastases at the diagnosis moment, thus, treatment options are restricted, and the survival rate is reserved. Case report: We presented the case of 59-year-old patient, diagnosed with non-functional well-differentiated pancreatic neuroendocrine tumor grade II (NET G2) with the presence of chromogranin A, synaptophysin and somatostatin receptor 2, together with liver and bone metastases. Patient underwent a surgical excision of the pancreatic tumor, started long-acting somatostatin analogues (octreotide), interferon therapy for liver metastases and local radiotherapy for bone metastases. After one year, the patient developed diabetes, needing insulin therapy. At approximately three years after the diagnosis, the patient was still living, had a good quality of life, and was free of local recurrence of the tumor or other metastases. Conclusion: Our case report presented a rare case of metastatic non-functional well-differentiated pancreatic neuroendocrine tumor, involving a multidisciplinary therapeutic approach in order to obtain a good long-term survival.

PMID: 27928440 [PubMed - indexed for MEDLINE]

http://ift.tt/2mPUVuk